famotidine has been researched along with Ache in 22 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty patients with symptomatic duodenal ulcer were randomized to receive either omeprazole (20 mg each morning) or famotidine (40 mg at night time) for 2-4 weeks in a double-blind parallel group clinical trial." | 9.07 | Omeprazole versus famotidine in the healing and relapse of duodenal ulcer. ( Dasarathy, S; Misra, SC; Sharma, MP, 1993) |
| "A randomized controlled study comparing once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers was carried out in 179 Japanese patients." | 9.07 | A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers. ( Arita, M; Iida, M; Koga, T; Okabe, N; Okada, M; Okada, Y; Sakurai, T; Yao, T, 1992) |
| "Famotidine (40 mg) and 800 mg cimetidine as single night-time doses were compared in a randomized, double-blind, multicentre study of acute treatment for duodenal ulceration." | 9.06 | Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer. ( Booth, SN; Cochran, KM; Cottrell, J; Crowe, J; Dickinson, RJ; Kennedy, NP; Lee, FI; Mann, SG, 1989) |
| "This multicentric, double-blind and prospective study, which involved 41 French Gastroenterology Units, was designed to evaluate the efficacy and safety of famotidine, 40 mg at bedtime, compared to single dose ranitidine, 300 mg, in promoting the healing of duodenal ulcer." | 9.06 | [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial]. ( Delvaux, M; Hagège, CG; Ribet, A, 1989) |
| "A multicenter, double-blind, randomized, controlled study was conducted in 234 duodenal ulcer patients to compare the efficacy and safety of the H2-receptor antagonists famotidine and ranitidine in the treatment of duodenal ulcer." | 9.06 | Comparison of once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of duodenal ulcer. A multicenter, double-blind, controlled study. ( Boero, A; Camarri, E; Crespi, M; De Pretis, G; Dobrilla, G; Fontana, G; Ideo, G; Manenti, F; Marenco, G; Piazzi, L, 1987) |
| "The efficacy of famotidine, a potent new long-acting H2 receptor antagonist, was compared with cimetidine in 78 patients with endoscopically proven acute duodenal ulcers." | 9.06 | Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. ( Fölsch, UR; Hartmann, H, 1988) |
| "An integrated analysis of the fifteen published prospective multicenter studies that have examined the safety and efficacy of famotidine for the short-term (13) and maintenance (2) therapy of duodenal ulcer included over 2,600 patients." | 9.06 | Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide. ( Reynolds, JC, 1988) |
| "The aim of the present investigation was to study the efficacy and safety of famotidine (MK-208), a new, potent, histamine H2 receptor antagonist, in promoting the healing of active gastric ulcer when compared to placebo." | 9.05 | Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study. ( Barbara, L; Bianchi Porro, G; Blasi, A; Carratelli, L; Cheli, R; Corinaldesi, R; Lazzaroni, M; Mangiameli, A; Paoluzi, P; Torsoli, A, 1985) |
| "We conducted an 8-week, double-blind, randomized, placebo-controlled multicenter trial (Austria and Germany) to determine whether famotidine would speed healing or relief of symptoms in patients with benign gastric ulcer." | 9.05 | Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany. ( Dammann, HG; Hentschel, E; Müller, P; Simon, B; Walter, TA, 1985) |
| "In order to evaluate the efficacity and tolerance of Famotidine in the treatment of gastric ulcer, in Lebanese patients, we conducted a prospective open study in twenty one patients with benign gastric ulcer." | 7.68 | [Famotidine in the treatment of stomach ulcer]. ( Khoury, K; Nassr, W; Sayegh, R, 1992) |
| " In view of possible increased patient compliance with a simplified dosage regimen, famotidine 40 mg h." | 6.66 | Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer. ( Bianchi Porro, G; Cook, T; Dicenta, C; Humphries, TJ, 1987) |
| "The aim of the study was to assess effects of H2-blocker of the IIId generation famotidine (quamatel) on the progression of acute and chronic pancreatitis and intensity of pain in patients with pancreatitis." | 5.09 | [Quamatel in the treatment of acute and chronic pancreatitis]. ( Belousova, EA; Dolgova, MB; Filizhanko, VN; Lovakov, AI; Nikulin, IV; Shemeneva, EG; Zlatkin, AR, 2000) |
| "Sixty patients with symptomatic duodenal ulcer were randomized to receive either omeprazole (20 mg each morning) or famotidine (40 mg at night time) for 2-4 weeks in a double-blind parallel group clinical trial." | 5.07 | Omeprazole versus famotidine in the healing and relapse of duodenal ulcer. ( Dasarathy, S; Misra, SC; Sharma, MP, 1993) |
| "A randomized controlled study comparing once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers was carried out in 179 Japanese patients." | 5.07 | A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers. ( Arita, M; Iida, M; Koga, T; Okabe, N; Okada, M; Okada, Y; Sakurai, T; Yao, T, 1992) |
| "Famotidine (40 mg) and 800 mg cimetidine as single night-time doses were compared in a randomized, double-blind, multicentre study of acute treatment for duodenal ulceration." | 5.06 | Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer. ( Booth, SN; Cochran, KM; Cottrell, J; Crowe, J; Dickinson, RJ; Kennedy, NP; Lee, FI; Mann, SG, 1989) |
| "This multicentric, double-blind and prospective study, which involved 41 French Gastroenterology Units, was designed to evaluate the efficacy and safety of famotidine, 40 mg at bedtime, compared to single dose ranitidine, 300 mg, in promoting the healing of duodenal ulcer." | 5.06 | [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial]. ( Delvaux, M; Hagège, CG; Ribet, A, 1989) |
| "A multicenter, double-blind, randomized, controlled study was conducted in 234 duodenal ulcer patients to compare the efficacy and safety of the H2-receptor antagonists famotidine and ranitidine in the treatment of duodenal ulcer." | 5.06 | Comparison of once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of duodenal ulcer. A multicenter, double-blind, controlled study. ( Boero, A; Camarri, E; Crespi, M; De Pretis, G; Dobrilla, G; Fontana, G; Ideo, G; Manenti, F; Marenco, G; Piazzi, L, 1987) |
| "The efficacy of famotidine, a potent new long-acting H2 receptor antagonist, was compared with cimetidine in 78 patients with endoscopically proven acute duodenal ulcers." | 5.06 | Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. ( Fölsch, UR; Hartmann, H, 1988) |
| "An integrated analysis of the fifteen published prospective multicenter studies that have examined the safety and efficacy of famotidine for the short-term (13) and maintenance (2) therapy of duodenal ulcer included over 2,600 patients." | 5.06 | Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide. ( Reynolds, JC, 1988) |
| "The aim of the present investigation was to study the efficacy and safety of famotidine (MK-208), a new, potent, histamine H2 receptor antagonist, in promoting the healing of active gastric ulcer when compared to placebo." | 5.05 | Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study. ( Barbara, L; Bianchi Porro, G; Blasi, A; Carratelli, L; Cheli, R; Corinaldesi, R; Lazzaroni, M; Mangiameli, A; Paoluzi, P; Torsoli, A, 1985) |
| "We conducted an 8-week, double-blind, randomized, placebo-controlled multicenter trial (Austria and Germany) to determine whether famotidine would speed healing or relief of symptoms in patients with benign gastric ulcer." | 5.05 | Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany. ( Dammann, HG; Hentschel, E; Müller, P; Simon, B; Walter, TA, 1985) |
| "In order to evaluate the efficacity and tolerance of Famotidine in the treatment of gastric ulcer, in Lebanese patients, we conducted a prospective open study in twenty one patients with benign gastric ulcer." | 3.68 | [Famotidine in the treatment of stomach ulcer]. ( Khoury, K; Nassr, W; Sayegh, R, 1992) |
| "A multicentre, randomized, double-dummy control trial compared the efficacy of two famotidine dosage regimens for the treatment of acute gastric mucosal lesions." | 2.66 | Clinical evaluation of 20 mg/day famotidine in the treatment of acute gastric mucosal lesions. ( Miwa, T, 1989) |
| " In view of possible increased patient compliance with a simplified dosage regimen, famotidine 40 mg h." | 2.66 | Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer. ( Bianchi Porro, G; Cook, T; Dicenta, C; Humphries, TJ, 1987) |
| "Atropine did not inhibit the antinociceptive effects of both mepyramine and famotidine on formalin-induced nociception." | 1.35 | Effects of mepyramine and famotidine on the physostigmine-induced antinociception in the formalin test in rats. ( Mojtahedin, A; Tamaddonfard, E; Zanbouri, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (54.55) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stokes, NA | 1 |
| Lemos, JP | 1 |
| Mojtahedin, A | 1 |
| Tamaddonfard, E | 1 |
| Zanbouri, A | 1 |
| Birk, JW | 1 |
| Myers, M | 1 |
| Osipenko, MF | 1 |
| Venzhina, IuIu | 1 |
| Turton, DB | 1 |
| Shakir, KM | 1 |
| Misra, SC | 1 |
| Dasarathy, S | 1 |
| Sharma, MP | 1 |
| Netzer, P | 1 |
| Brabetz-Höfliger, A | 1 |
| Bründler, R | 1 |
| Flogerzi, B | 1 |
| Hüsler, J | 1 |
| Halter, F | 1 |
| Belousova, EA | 1 |
| Zlatkin, AR | 1 |
| Nikulin, IV | 1 |
| Lovakov, AI | 1 |
| Filizhanko, VN | 1 |
| Shemeneva, EG | 1 |
| Dolgova, MB | 1 |
| Sayegh, R | 1 |
| Khoury, K | 1 |
| Nassr, W | 1 |
| Okada, M | 1 |
| Yao, T | 1 |
| Sakurai, T | 1 |
| Arita, M | 1 |
| Okabe, N | 1 |
| Iida, M | 1 |
| Okada, Y | 1 |
| Koga, T | 1 |
| Cochran, KM | 2 |
| Cockel, R | 1 |
| Crowe, J | 2 |
| Dickinson, RJ | 2 |
| Gent, AE | 1 |
| Kennedy, NP | 2 |
| Royston, CM | 1 |
| Cedar, E | 1 |
| Mann, SG | 2 |
| Lee, FI | 1 |
| Booth, SN | 1 |
| Cottrell, J | 1 |
| Reynolds, JC | 2 |
| Miwa, T | 1 |
| Delvaux, M | 1 |
| Hagège, CG | 1 |
| Ribet, A | 1 |
| Barbara, L | 2 |
| Corinaldesi, R | 2 |
| Bianchi Porro, G | 3 |
| Lazzaroni, M | 2 |
| Blasi, A | 2 |
| Mangiameli, A | 2 |
| Carratelli, L | 2 |
| Wilkins, A | 1 |
| Cheli, R | 2 |
| Bovero, E | 1 |
| Paoluzi, P | 1 |
| Torsoli, A | 1 |
| Dicenta, C | 1 |
| Cook, T | 1 |
| Humphries, TJ | 1 |
| Dobrilla, G | 1 |
| De Pretis, G | 1 |
| Piazzi, L | 1 |
| Boero, A | 1 |
| Camarri, E | 1 |
| Crespi, M | 1 |
| Fontana, G | 1 |
| Ideo, G | 1 |
| Manenti, F | 1 |
| Marenco, G | 1 |
| Hartmann, H | 1 |
| Fölsch, UR | 1 |
| Dammann, HG | 1 |
| Walter, TA | 1 |
| Hentschel, E | 1 |
| Müller, P | 1 |
| Simon, B | 1 |
16 trials available for famotidine and Ache
| Article | Year |
|---|---|
Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
Topics: Absenteeism; Adult; Analgesics; Antacids; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; H | 1993 |
Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Topics: Administration, Oral; Adult; Antacids; Calcium Carbonate; Carbonates; Double-Blind Method; Dyspepsia | 1998 |
[Quamatel in the treatment of acute and chronic pancreatitis].
Topics: Acute Disease; Adult; Chronic Disease; Disease Progression; Famotidine; Female; Histamine H2 Antagon | 2000 |
A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers.
Topics: Adult; Aged; Drug Administration Schedule; Famotidine; Female; Gastroscopy; Humans; Male; Middle Age | 1992 |
Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Famotidine; Female; Gastroscopy; Humans; Male; Middle | 1989 |
Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Cimetidine; Double-Blind M | 1989 |
Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Duodenal | 1989 |
Clinical evaluation of 20 mg/day famotidine in the treatment of acute gastric mucosal lesions.
Topics: Adult; Aged; Anti-Ulcer Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Famotidi | 1989 |
[Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Topics: Acute Disease; Adolescent; Adult; Aged; Cicatrix; Clinical Trials as Topic; Double-Blind Method; Dru | 1989 |
Famotidine in the management of duodenal ulcer: experience in Italy.
Topics: Adult; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Famotidine; | 1985 |
Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study.
Topics: Adolescent; Adult; Aged; Antacids; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; | 1985 |
Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
Topics: Acute Disease; Adult; Antacids; Duodenal Ulcer; Famotidine; Female; Histamine H2 Antagonists; Humans | 1987 |
Comparison of once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of duodenal ulcer. A multicenter, double-blind, controlled study.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule | 1987 |
Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Me | 1988 |
Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide.
Topics: Drug Administration Schedule; Duodenal Ulcer; Evaluation Studies as Topic; Famotidine; Humans; Meta- | 1988 |
Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule | 1985 |
6 other studies available for famotidine and Ache
| Article | Year |
|---|---|
Male patient with throat swelling and painful swallowing.
Topics: Adenoids; Adult; Angioedema; Anti-Inflammatory Agents; Deglutition Disorders; Dexamethasone; Diphenh | 2013 |
Effects of mepyramine and famotidine on the physostigmine-induced antinociception in the formalin test in rats.
Topics: Analgesics; Animals; Atropine; Drug Interactions; Famotidine; Formaldehyde; Histamine H1 Antagonists | 2008 |
A fixed dose combination of ibuprofen and famotidine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials, Phase III as Topic; Dru | 2009 |
[Problems of excretory insufficiency of the pancreas].
Topics: Adolescent; Adult; Aged; Famotidine; Feces; Female; Histamine H2 Antagonists; Humans; Male; Middle A | 2004 |
Galactorrhea caused by esophagitis.
Topics: Adult; Anti-Ulcer Agents; Bethanechol; Esophagitis; Famotidine; Female; Galactorrhea; Gastroesophage | 1995 |
[Famotidine in the treatment of stomach ulcer].
Topics: Adult; Aged; Biopsy; Drug Tolerance; Famotidine; Female; Gastroscopy; Humans; Male; Middle Aged; Pai | 1992 |